Copyright
©The Author(s) 2022.
World J Gastrointest Endosc. Jul 16, 2022; 14(7): 416-423
Published online Jul 16, 2022. doi: 10.4253/wjge.v14.i7.416
Published online Jul 16, 2022. doi: 10.4253/wjge.v14.i7.416
Table 2 Indication for endoscopic procedures
| Indication for endoscopy (n = 86) | |
| GI bleed | 29 (33.7%) |
| Symptomatic (weight loss, abdominal pain, diarrhea, nausea, vomiting, obstruction) | 22 (25.6%) |
| Anemia | 5 (5.8%) |
| Elective diagnostic + follow-up | 16 (18.6%) |
| Dysphagia | 9 (10.5%) |
| Enteral access | 5 (5.8%) |
- Citation: Azam M, Hudgi A, Uy PP, Makhija J, Yap JEL. Safety of endoscopy in patients undergoing treatments with antiangiogenic agents: A 5-year retrospective review. World J Gastrointest Endosc 2022; 14(7): 416-423
- URL: https://www.wjgnet.com/1948-5190/full/v14/i7/416.htm
- DOI: https://dx.doi.org/10.4253/wjge.v14.i7.416